APA (7th ed.) Citation

CS, C., T, L., XX, L., R, G., N, L., V, K., . . . TM, W. (2025). Colon-targeted complement C5a1 receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitis. British journal of pharmacology, 182(16), 3852. https://doi.org/10.1111/bph.70056

Chicago Style (17th ed.) Citation

CS, Cui, et al. "Colon-targeted Complement C5a1 Receptor Inhibition Using PH-sensitive Nanoparticles Ameliorates Experimental Colitis." British Journal of Pharmacology 182, no. 16 (2025): 3852. https://doi.org/10.1111/bph.70056.

MLA (9th ed.) Citation

CS, Cui, et al. "Colon-targeted Complement C5a1 Receptor Inhibition Using PH-sensitive Nanoparticles Ameliorates Experimental Colitis." British Journal of Pharmacology, vol. 182, no. 16, 2025, p. 3852, https://doi.org/10.1111/bph.70056.